SpringWorks Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

176,719

Value ($000)

8,304

Weight

0.0%

2020 Q3 - 2025 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	8,304	0.0%	176,719	6/30/2025
2025 Q1	5/19/2025	5,348	0.0%	121,177	3/31/2025
2024 Q4	2/14/2025	4,301	0.0%	119,052	12/31/2024
2024 Q3	11/14/2024	3,196	0.0%	99,737	9/30/2024
2024 Q2	8/14/2024	4,281	0.0%	113,635	6/30/2024
2024 Q1	5/15/2024	3,483	0.0%	70,761	3/31/2024
2023 Q4	2/14/2024	2,537	0.0%	69,513	12/31/2023
2023 Q3	11/13/2023	1,271	0.0%	54,966	9/30/2023
2023 Q2	8/11/2023	1,097	0.0%	42,630	6/30/2023
2023 Q1	5/15/2023	1,097	0.0%	42,630	3/31/2023
2022 Q4	2/14/2023	700	0.0%	26,918	12/31/2022
2022 Q3	11/14/2022	685	0.0%	24,021	9/30/2022
2022 Q2	8/12/2022	392	0.0%	15,908	6/30/2022
2022 Q1	5/16/2022	1,180	0.0%	20,913	3/31/2022
2021 Q4	2/14/2022	1,296	0.0%	20,913	12/31/2021
2021 Q3	11/15/2021	1,327	0.0%	20,913	9/30/2021
2021 Q2	8/16/2021	1,723	0.0%	20,913	6/30/2021
2021 Q1	5/14/2021	1,427	0.0%	19,400	3/31/2021
2020 Q4	3/1/2021	1,131	0.0%	15,600	12/31/2020
2020 Q3	11/13/2020	496	0.0%	10,400	9/30/2020